FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168811139> ?p ?o ?g. }

• W3168811139 abstract "Background: Mycoplasma pneumoniae pneumonia (MPP) causes flu-like symptoms in children, increasing the burden on the health and education systems. In China, traditional Chinese medicine oral liquids (TCMOLs) combined with azithromycin (TCMOLs + Azithromycin) is commonly used to treat MPP in children. However, TCMOLs with the optimal clinical applicability remain unknown. Here, we evaluated the clinical effectiveness and safety of TCMOLs + Azithromycin in children with MPP. Methods: We searched PubMed, Embase, Cochrane Library, Ovid, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, and VIP information resource integration service platform databases for eligible randomized controlled trials (RCTs) published from database inception to October 2020. Two reviewers independently performed data extraction and risk of bias assessment. After Bayesian random effect modeling and surface under the cumulative ranking curve (SUCRA) scoring, we ranked each intervention. We assessed heterogeneity using multivariate meta-regression for potential modifiers and used the Grading of Recommendations, Assessment, Development, and Evaluation to rate pooled evidence’s certainty. Results: In the 63 included RCTs with 6,410 children, five different TCMOLs were combined with azithromycin. TCMOLs + Azithromycin had significantly better primary outcomes than did azithromycin alone. Of all TCMOLs, Xiaoer Xiaoji Zhike (XEXJZK)+Azithromycin showed the best effectiveness with respect to the response rate (odds ratio [OR] = 6.5, 95% credible interval [CrI] = 4.3–10; low certainty) and pulmonary rales disappearance time (mean difference [MD] = −2.1, 95% CrI: −2.9 to −1.2; low certainty) with SUCRA 85 and 80%, respectively. Pudilan Xiaoyan + Azithromycin showed the highest effectiveness with respect to cough disappearance time (MD = −2.6, 95% CrI: −3.4 to −1.7; very low certainty) and fever disappearance time (MD = −1.8, 95% CrI: −2.3 to −1.3; very low certainty) with SUCRA 87 and 87%, respectively. The difference in the adverse effects between TCMOLs + Azithromycin and azithromycin alone was nonsignificant. Conclusion: Of the different TCMOLs, XEXJZK may be the best option to combine with azithromycin to treat children with MPP. However, our results should be interpreted with caution due to the low certainty of evidence. In general, TCMOLs’ safety remains unclear because of a lack of evidence. More high-quality RCTs are needed to further evaluate efficacy and safety of these TCMOLs." @default.
• W3168811139 created "2021-06-22" @default.
• W3168811139 creator A5004261131 @default.
• W3168811139 creator A5030751228 @default.
• W3168811139 creator A5033820324 @default.
• W3168811139 creator A5035429453 @default.
• W3168811139 creator A5037160914 @default.
• W3168811139 creator A5043706949 @default.
• W3168811139 creator A5066253638 @default.
• W3168811139 creator A5075421033 @default.
• W3168811139 creator A5087631945 @default.
• W3168811139 date "2021-05-28" @default.
• W3168811139 modified "2023-09-27" @default.
• W3168811139 title "Traditional Chinese Medicine Oral Liquids Combined With Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Bayesian Network Meta-Analysis" @default.
• W3168811139 cites W1602176441 @default.
• W3168811139 cites W1617328014 @default.
• W3168811139 cites W2005490754 @default.
• W3168811139 cites W2005501262 @default.
• W3168811139 cites W2018297766 @default.
• W3168811139 cites W2042371919 @default.
• W3168811139 cites W2062375051 @default.
• W3168811139 cites W2078502875 @default.
• W3168811139 cites W2084954994 @default.
• W3168811139 cites W2085392995 @default.
• W3168811139 cites W2092502027 @default.
• W3168811139 cites W2096718691 @default.
• W3168811139 cites W2098923148 @default.
• W3168811139 cites W2104675861 @default.
• W3168811139 cites W2112778274 @default.
• W3168811139 cites W2125793611 @default.
• W3168811139 cites W2128177294 @default.
• W3168811139 cites W2155798268 @default.
• W3168811139 cites W2164073249 @default.
• W3168811139 cites W2169205464 @default.
• W3168811139 cites W2190271138 @default.
• W3168811139 cites W2418375252 @default.
• W3168811139 cites W2470455431 @default.
• W3168811139 cites W2536614667 @default.
• W3168811139 cites W2580859205 @default.
• W3168811139 cites W2749455292 @default.
• W3168811139 cites W2751530471 @default.
• W3168811139 cites W2766211624 @default.
• W3168811139 cites W2774267806 @default.
• W3168811139 cites W2787374601 @default.
• W3168811139 cites W2804472922 @default.
• W3168811139 cites W2889576957 @default.
• W3168811139 cites W2945717288 @default.
• W3168811139 cites W2986573157 @default.
• W3168811139 cites W3004247531 @default.
• W3168811139 cites W3005207288 @default.
• W3168811139 cites W3025255764 @default.
• W3168811139 cites W3028873676 @default.
• W3168811139 cites W3042641873 @default.
• W3168811139 cites W4239909494 @default.
• W3168811139 cites W4293170732 @default.
• W3168811139 doi "https://doi.org/10.3389/fphar.2021.652412" @default.
• W3168811139 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8194818" @default.
• W3168811139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34122075" @default.
• W3168811139 hasPublicationYear "2021" @default.
• W3168811139 type Work @default.
• W3168811139 sameAs 3168811139 @default.
• W3168811139 citedByCount "3" @default.
• W3168811139 countsByYear W31688111392021 @default.
• W3168811139 countsByYear W31688111392022 @default.
• W3168811139 countsByYear W31688111392023 @default.
• W3168811139 crossrefType "journal-article" @default.
• W3168811139 hasAuthorship W3168811139A5004261131 @default.
• W3168811139 hasAuthorship W3168811139A5030751228 @default.
• W3168811139 hasAuthorship W3168811139A5033820324 @default.
• W3168811139 hasAuthorship W3168811139A5035429453 @default.
• W3168811139 hasAuthorship W3168811139A5037160914 @default.
• W3168811139 hasAuthorship W3168811139A5043706949 @default.
• W3168811139 hasAuthorship W3168811139A5066253638 @default.
• W3168811139 hasAuthorship W3168811139A5075421033 @default.
• W3168811139 hasAuthorship W3168811139A5087631945 @default.
• W3168811139 hasBestOaLocation W31688111391 @default.
• W3168811139 hasConcept C126322002 @default.
• W3168811139 hasConcept C156957248 @default.
• W3168811139 hasConcept C168563851 @default.
• W3168811139 hasConcept C177713679 @default.
• W3168811139 hasConcept C2776478404 @default.
• W3168811139 hasConcept C2777914695 @default.
• W3168811139 hasConcept C2778907293 @default.
• W3168811139 hasConcept C2779215961 @default.
• W3168811139 hasConcept C2779706735 @default.
• W3168811139 hasConcept C44249647 @default.
• W3168811139 hasConcept C501593827 @default.
• W3168811139 hasConcept C71924100 @default.
• W3168811139 hasConcept C86803240 @default.
• W3168811139 hasConcept C89423630 @default.
• W3168811139 hasConcept C95190672 @default.
• W3168811139 hasConceptScore W3168811139C126322002 @default.
• W3168811139 hasConceptScore W3168811139C156957248 @default.
• W3168811139 hasConceptScore W3168811139C168563851 @default.
• W3168811139 hasConceptScore W3168811139C177713679 @default.
• W3168811139 hasConceptScore W3168811139C2776478404 @default.
• W3168811139 hasConceptScore W3168811139C2777914695 @default.
• W3168811139 hasConceptScore W3168811139C2778907293 @default.
• W3168811139 hasConceptScore W3168811139C2779215961 @default.
• W3168811139 hasConceptScore W3168811139C2779706735 @default.

• next